Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

STERIS plc (Ireland) Ordinary Shares (NY:STE)

222.23 +2.21 (+1.00%)
Official Closing Price Updated: 7:00 PM EDT, Apr 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about STERIS plc (Ireland) Ordinary Shares

< Previous 1 2 3 4 5 Next >
STERIS to Host a Conference Call for Fiscal 2023 Third Quarter Financial Results on February 9, 2023
From STERIS plc
Via GlobeNewswire
2 Monster Stocks to Buy Without Any Hesitation
These two companies are prepared to grow regardless of the economy or the stock market's moods. 
Via The Motley Fool
NVIDIA To $225? Plus Raymond James Cuts PT On This Stock By 81%
Oppenheimer cut the price target on NVIDIA Corporation (NASDAQ: NVDA) from $250 to $225. Oppenheimer analyst Rick Schafer maintained an Outperform rating on the stock. NVIDIA shares rose 0.9% to... 
Via Benzinga
STERIS Announces Financial Results for Fiscal 2023 Second Quarter
From STERIS plc
Via GlobeNewswire
Needham Downgrades This Medical Equipment Stock Due To Lawsuit Risk
Via Benzinga
Expert Ratings for Steris
Analysts have provided the following ratings for Steris (NYSE:STE) within the last quarter: 
Via Benzinga
Earnings Scheduled For May 11, 2022
Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter. 
Via Benzinga
Steris Q3 Sales Jump 50% To $1.2B, Revises FY22 Guidance
Steris plc (NYSE: STE)  
Via Benzinga
STERIS Declares $0.47 per share Dividend
From STERIS plc
Via GlobeNewswire
Buy These 2 Evergreen Growth Stocks Today to Beat the Bear Market Blues
Both have loyal and long-term customers, as well as plenty of accessible growth for years to come. 
Via The Motley Fool
STERIS to Host a Conference Call for Fiscal 2023 Second Quarter Financial Results on November 10, 2022
From STERIS plc
Via GlobeNewswire
3 Fast-Growing Medical Dividend Stocks
Sometimes, the strongest payout growth can be found among the future Dividend Aristocrats, not the current ones. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For September 23, 2022
Upgrades 
Via Benzinga
AMD, SolarEdge Technologies And Some Other Big Stocks Moving Lower On Wednesday
  Rocky Brands, Inc. (NASDAQ: RCKY) dipped 21.6% to $26.62 after the company reported worse-than-expected Q2 EPS results. 
Via Benzinga
Steris: Q1 Earnings Insights
Steris (NYSE:STE) reported its Q1 earnings results on Tuesday, August 2, 2022 at 04:30 PM. Here's what investors need to know about the announcement. Earnings Steris missed estimated earnings by 0.52%,... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2022
Upgrades 
Via Benzinga
Earnings Scheduled For August 2, 2022
Companies Reporting Before The Bell • Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion. 
Via Benzinga
ShockWave Medical Stock Scores Relative Strength Rating Jump To 89
ShockWave Medical stock saw a positive improvement to its Relative Strength (RS) Rating on Monday, rising from 77 to 89. 
Via Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Ominous Death Cross Forms On Steris's Chart
If history is any guide, there may be trouble ahead for shares of Steris (NYSE:STE). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock. 
Via Benzinga
ShockWave Medical Stock Shows Rising Price Performance With Jump To 91 RS Rating
On Monday, ShockWave Medical stock received an upgrade to its Relative Strength (RS) Rating, from 86 to 91. 
Via Investor's Business Daily
Steris: Q4 Earnings Insights
Steris (NYSE:STE) reported its Q4 earnings results on Wednesday, May 11, 2022 at 04:30 PM. Here's what investors need to know about the announcement. Earnings Steris beat estimated earnings by 0.99%,... 
Via Benzinga
Stocks That Hit 52-Week Highs On Thursday
On Thursday, 75 stocks made new 52-week highs. Interesting Highlights From Today's 52-Week Highs: The largest company by market cap to hit a new 52-week high... 
Via Benzinga
UnitedHealth, Vertex Lead Five Stocks Looking Healthy In A Weak Market
Health care stocks have some advantages in the current market environment. 
Via Investor's Business Daily
10 Biggest Price Target Changes For Thursday
Macquarie boosted the price target on Twilio Inc. (NYSE: TWLO) from $281 to $306. Twilio shares jumped 20.4% to $243.23 in pre-market trading. 
Via Benzinga
Recap: Steris Q3 Earnings
Steris (NYSE:STE) reported its Q3 earnings results on Tuesday, February 8, 2022 at 04:30 PM. Here's what investors need to know about the announcement. Earnings Steris beat estimated earnings by 7.61%,... 
Via Benzinga
Evoqua Water Technologies Closes Acquisition of Renal Business from STERIS
From Evoqua Water Technologies
Via Business Wire
Earnings Scheduled For February 8, 2022
Companies Reporting Before The Bell • Pfizer (NYSE:PFE) is likely to report quarterly earnings at $0.87 per share on revenue of $24.20 billion. 
Via Benzinga
Evoqua Water To Acquire Steris' Renal Business For $196.3M
Evoqua Water Technologies Corp (NYSE: AQUA) has agreed to acquire the assets of the renal business of Steris PLC (NYSE: STE) for $196.3 million. The... 
Via Benzinga
If You Invested $100 Over The Past 5 Years In This Stock, Here's How Much You Would Have Today
Steris (NYSE:STE) has outperformed the market over the past 5 years by 11.52% on an annualized basis. Buying $100.00 In STE: 5 years ago, an investor could have purchased 1.53... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.